Humalys Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Humalys General Information

Description

Operator of a biotech research and development company. The company develops a technology that is generating human monoclonal antibodies for therapeutic and diagnostic applications.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
  • 41 Quai Fulchiron
  • 69005 Lyon
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Humalys Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Humalys‘s full profile, request access.

Request a free trial